Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $6000.0.

  • Biofrontera's Tax Provisions rose 10000.0% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $23000.0, marking a year-over-year increase of 2777.78%. This contributed to the annual value of $22000.0 for FY2024, which is 5714.29% up from last year.
  • As of Q3 2025, Biofrontera's Tax Provisions stood at $6000.0, which was up 10000.0% from $21000.0 recorded in Q2 2025.
  • Biofrontera's 5-year Tax Provisions high stood at $44000.0 for Q2 2021, and its period low was -$6000.0 during Q4 2023.
  • For the 5-year period, Biofrontera's Tax Provisions averaged around $8277.8, with its median value being $4000.0 (2021).
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 290000.0% in 2022, then crashed by 70000.0% in 2023.
  • Biofrontera's Tax Provisions (Quarter) stood at $5000.0 in 2021, then crashed by 80.0% to $1000.0 in 2022, then tumbled by 700.0% to -$6000.0 in 2023, then skyrocketed by 50.0% to -$3000.0 in 2024, then soared by 300.0% to $6000.0 in 2025.
  • Its last three reported values are $6000.0 in Q3 2025, $21000.0 for Q2 2025, and -$1000.0 during Q1 2025.